Bank of America Securities Sticks to Its Buy Rating for BioMarin Pharmaceutical (BMRN)
at www.tipranks.com (Fri, 9-Oct 9:16 AM)
RBC Capital Keeps Their Hold Rating on BioMarin Pharmaceutical (BMRN)
at www.tipranks.com (Thu, 8-Oct 9:46 PM)
at www.tipranks.com (Wed, 7-Oct 9:20 AM)
BioMarin Q3 financial results to see IPR&D expense impact of $283M
at seekingalpha.com (Tue, 6-Oct 6:28 PM)
BioMarin Highlights Growth Strategy Ahead of 2026 Canaccord Conference Presentation
Market Chameleon (Mon, 10-Aug 9:20 AM)
